Dolby Laboratories (NYSE:DLB – Get Free Report) has been assigned an average rating of “Moderate Buy” from the five brokerages that are currently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $90.75.
A number of analysts recently commented on DLB shares. Wall Street Zen raised Dolby Laboratories from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. Rosenblatt Securities reissued a “buy” rating and issued a $85.00 target price on shares of Dolby Laboratories in a research note on Thursday, June 11th. Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a report on Wednesday, June 24th. Finally, Barrington Research reaffirmed an “outperform” rating and set a $90.00 price target on shares of Dolby Laboratories in a research note on Monday, June 15th.
Check Out Our Latest Stock Report on DLB
Dolby Laboratories Price Performance
Dolby Laboratories (NYSE:DLB – Get Free Report) last announced its earnings results on Thursday, April 30th. The electronics maker reported $1.37 EPS for the quarter, beating analysts’ consensus estimates of $1.31 by $0.06. The firm had revenue of $395.63 million for the quarter, compared to analysts’ expectations of $385.80 million. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.Dolby Laboratories’s quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.34 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. As a group, research analysts expect that Dolby Laboratories will post 3.21 EPS for the current fiscal year.
Dolby Laboratories Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th were paid a dividend of $0.36 per share. The ex-dividend date of this dividend was Tuesday, May 12th. This represents a $1.44 annualized dividend and a dividend yield of 2.9%. Dolby Laboratories’s dividend payout ratio is presently 56.92%.
Insider Activity
In other Dolby Laboratories news, SVP John D. Couling sold 7,667 shares of Dolby Laboratories stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $53.20, for a total value of $407,884.40. Following the completion of the sale, the senior vice president directly owned 118,727 shares of the company’s stock, valued at approximately $6,316,276.40. The trade was a 6.07% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Shriram Revankar sold 3,000 shares of the business’s stock in a transaction on Friday, May 15th. The shares were sold at an average price of $54.90, for a total value of $164,700.00. Following the completion of the transaction, the senior vice president owned 80,603 shares of the company’s stock, valued at $4,425,104.70. This trade represents a 3.59% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 47,458 shares of company stock worth $2,639,537 in the last three months. 37.93% of the stock is owned by insiders.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Assenagon Asset Management S.A. raised its holdings in shares of Dolby Laboratories by 88.9% in the 2nd quarter. Assenagon Asset Management S.A. now owns 104,202 shares of the electronics maker’s stock worth $5,479,000 after purchasing an additional 49,044 shares during the period. CX Institutional grew its holdings in shares of Dolby Laboratories by 14.4% during the 2nd quarter. CX Institutional now owns 12,727 shares of the electronics maker’s stock worth $669,000 after purchasing an additional 1,605 shares during the period. Pacer Advisors Inc. increased its position in Dolby Laboratories by 8.0% during the 1st quarter. Pacer Advisors Inc. now owns 516,292 shares of the electronics maker’s stock worth $31,008,000 after purchasing an additional 38,389 shares in the last quarter. Edgestream Partners L.P. increased its position in Dolby Laboratories by 232.8% during the 1st quarter. Edgestream Partners L.P. now owns 22,376 shares of the electronics maker’s stock worth $1,344,000 after purchasing an additional 15,652 shares in the last quarter. Finally, Amundi purchased a new position in Dolby Laboratories in the first quarter valued at approximately $280,000. Institutional investors and hedge funds own 58.56% of the company’s stock.
Dolby Laboratories Company Profile
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Featured Articles
- Five stocks we like better than Dolby Laboratories
- PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
